Sort
48,018 grants matching “immunotherapy”
Hexokinase 2 and cancer therapy
$574,013Nissim Hay · University Of Illinois At Chicago · R01 · FY2025 · CA
Single Cell Methods for Bioeffector Discovery and Analysis
$573,883Brian O Bachmann · Vanderbilt University · R01 · FY2020 · CA
Immunotherapeutic Modulation of Peanut Allergy
$573,881Scott H Sicherer · Icahn School Of Medicine At Mount Sinai · U19 · FY2006 · AI
IDENTIFYING BIOMARKERS OF RESPONSE AND RESISTANCE TO IMMUNOTHERAPY IN BLADDER CANCER
$573,850The Cleveland Clinic Foundation · · FY2020 · Defense Health Agency
The Role of the Tumor Suppressor ARID1A in R loop Homeostasis and Tumor Immunity
$573,836Diana Clare Hargreaves · Salk Institute For Biological Studies · R01 · FY2025 · CA
Fecal Microbiota Transplant and PD-1 blockade in Melanoma
$573,831Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
A NON-HUMAN PRIMATE MODEL OF TUBERCULOSIS AND AIDS
$573,820University Of Pittsburgh At Pittsburgh · R01 · FY2001 · AI
A HIGHLY SUPERIOR AND SELECTIVE CANCER IMMUNOTHERAPY-BASED APPROACH FOR TRIPLE-NEGATIVE BREAST CANCERS
$573,784Rector & Visitors Of The University Of Virginia · · FY2018 · Defense Health Agency
High-Specificity Imaging Agents for Aggressive Prostate Cancer
$573,775Martin G Pomper · Johns Hopkins University · R01 · FY2015 · CA
Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment
$573,726Laurie McLouth · University Of Kentucky · R01 · FY2025 · CA
Vaccine and radiation for the therapy of human cancers
$573,692James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$573,692James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Novel therapeutic approaches for enhancing anti-tumor immunity in SCLC
$573,659John V. Heymach · University Of Tx Md Anderson Can Ctr · U01 · FY2019 · CA
Elucidating genetics of response to immune checkpoint blockade in lung cancer
$573,644Naiyer A Rizvi · Columbia University Health Sciences · R01 · FY2017 · CA
Induced tolerogenic dendritic cell therapy of allergic diseases
$573,633Ulrich H Von Andrian · Massachusetts General Hospital · U19 · FY2013 · AI
Metabolism of cancer chemotherapeutics by the human gut microbiome
$573,622Peter James Turnbaugh · University Of California, San Francisco · R01 · FY2024 · CA
Activating Native Tumor Immunity with IL-33 Armored CARs
$573,520Yina Hsing Huang · Dartmouth College · R01 · FY2023 · CA
Whitlockite nanoparticle-based immunotherapy for bone metastasis
$573,510Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2019 · CA
Circulating biomarkers of clinical response to combination targeted therapies in neuroblastoma
$573,379Kieuhoa Tran Vo · University Of California, San Francisco · R01 · FY2024 · CA
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES
$573,371Warren S Pear · University Of Pennsylvania · T32 · FY2016 · CA
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
$573,297Elinor Karlsson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · CA
Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling
$573,258Casey S Greene · University Of Colorado Denver · R01 · FY2022 · CA
Neutrophil derived proteinases abolish the IFNG signature in NSCLC
$573,105A. McGarry Houghton · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Credentialing Models of Invasive Lobular Breast Cancer for Translational Research
$573,041Steffi Oesterreich · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Development of selective HDAC6 inhibitors to improve cancer immunotherapy
$573,024Alejandro V Villagra · Georgetown University · R01 · FY2025 · CA